Healthcare provider profile · identity verified

Brandon Stucky, MD

Family Practice · CASTLE ROCK, CO · NPI 1841729217

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	339	89
Levothyroxine Sodium	Levothyroxine Sodium	284	72
Atorvastatin Calcium	Atorvastatin Calcium	247	67
Losartan Potassium	Losartan Potassium	233	58
Lisinopril	Lisinopril	220	56
Rosuvastatin Calcium	Rosuvastatin Calcium	173	51
Gabapentin	Gabapentin	172	37
Potassium Chloride	Potassium Chloride	143	41
Pantoprazole Sodium	Pantoprazole Sodium	141	37
Furosemide	Furosemide	139	42
Simvastatin	Simvastatin	135	33
Omeprazole	Omeprazole	125	40
Hydrochlorothiazide	Hydrochlorothiazide	120	31
Warfarin Sodium	Warfarin Sodium	116	suppressed
Duloxetine Hcl	Duloxetine Hcl	107	23
Tamsulosin Hcl	Tamsulosin Hcl	107	29
Metformin Hcl	Metformin Hcl	91	25
Tramadol Hcl	Tramadol Hcl	83	19
Pravastatin Sodium	Pravastatin Sodium	82	23
Metoprolol Tartrate	Metoprolol Tartrate	81	19
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	80	24
Sertraline Hcl	Sertraline Hcl	75	15
Pioglitazone Hcl	Pioglitazone Hcl	73	21
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	67	14
Allopurinol	Allopurinol	66	14
Escitalopram Oxalate	Escitalopram Oxalate	66	11
Glipizide Er	Glipizide	66	15
Montelukast Sodium	Montelukast Sodium	66	22
Albuterol Sulfate Hfa	Albuterol Sulfate	65	23
Metformin Hcl Er	Metformin Hcl	65	21
Famotidine	Famotidine	63	13
Meloxicam	Meloxicam	63	15
Donepezil Hcl	Donepezil Hcl	51	13
Alendronate Sodium	Alendronate Sodium	50	14
Memantine Hcl	Memantine Hcl	50	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	49	11
Spironolactone	Spironolactone	49	17
Pregabalin	Pregabalin	48	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	48	11
Carvedilol	Carvedilol	45	suppressed
Lovastatin	Lovastatin	45	13
Ozempic	Semaglutide	45	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	43	14
Fluticasone Propionate	Fluticasone Propionate	42	19
Metoprolol Succinate	Metoprolol Succinate	42	15
Xarelto	Rivaroxaban	42	suppressed
Temazepam	Temazepam	40	suppressed
Eliquis	Apixaban	39	suppressed
Chlorthalidone	Chlorthalidone	36	11
Alprazolam	Alprazolam	35	12
Citalopram Hbr	Citalopram Hydrobromide	35	suppressed
Prednisone	Prednisone	31	20
Myrbetriq	Mirabegron	30	suppressed
Cephalexin	Cephalexin	28	16
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	28	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	27	suppressed
Mirtazapine	Mirtazapine	27	suppressed
Carbamazepine	Carbamazepine	26	suppressed
Finasteride	Finasteride	26	suppressed
Lorazepam	Lorazepam	26	suppressed
Trazodone Hcl	Trazodone Hcl	26	suppressed
Incruse Ellipta	Umeclidinium Bromide	25	suppressed
Mounjaro	Tirzepatide	25	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	23	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	23	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	22	suppressed
Glipizide	Glipizide	22	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	22	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	22	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	21	suppressed
Estradiol	Estradiol	21	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Verapamil Er	Verapamil Hcl	21	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	20	19
Ezetimibe	Ezetimibe	20	suppressed
Oxycodone Hcl	Oxycodone Hcl	20	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	20	16
Baclofen	Baclofen	19	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	19	suppressed
Paroxetine Hcl	Paroxetine Hcl	19	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	19	suppressed
Gemfibrozil	Gemfibrozil	18	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	18	suppressed
Symbicort	Budesonide/Formoterol Fumarate	18	suppressed
Aripiprazole	Aripiprazole	17	suppressed
Azithromycin	Azithromycin	17	15
Doxycycline Hyclate	Doxycycline Hyclate	17	11
Novolog Flexpen	Insulin Aspart	17	suppressed
Sucralfate	Sucralfate	17	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	17	suppressed
Atenolol	Atenolol	16	suppressed
Celecoxib	Celecoxib	16	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	16	suppressed
Digoxin	Digoxin	16	suppressed
Synthroid	Levothyroxine Sodium	16	suppressed
Breo Ellipta	Fluticasone/Vilanterol	14	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	14	suppressed
Diclofenac Sodium	Diclofenac Sodium	14	suppressed
Fluconazole	Fluconazole	14	suppressed
Lactulose	Lactulose	14	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	14	suppressed
Ropinirole Hcl	Ropinirole Hcl	14	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	14	suppressed
Buspirone Hcl	Buspirone Hcl	13	suppressed
Donepezil Hcl Odt	Donepezil Hcl	13	suppressed
Ipratropium Bromide	Ipratropium Bromide	13	suppressed
Jardiance	Empagliflozin	13	suppressed
Divalproex Sodium Er	Divalproex Sodium	12	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	12	suppressed
Fiasp Flextouch	Insulin Aspart (Niacinamide)	12	suppressed
Humalog Kwikpen U-100	Insulin Lispro	12	suppressed
Ramipril	Ramipril	12	suppressed
Testosterone	Testosterone	12	suppressed
Torsemide	Torsemide	12	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	12	suppressed
Ventolin Hfa	Albuterol Sulfate	12	suppressed
Bumetanide	Bumetanide	11	suppressed
Clonazepam	Clonazepam	11	suppressed
Fenofibrate	Fenofibrate	11	suppressed
Insulin Degludec Pen (U-100)	Insulin Degludec	11	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	11	suppressed
Lisdexamfetamine Dimesylate	Lisdexamfetamine Dimesylate	11	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	11	suppressed
Raloxifene Hcl	Raloxifene Hcl	11	suppressed
Solifenacin Succinate	Solifenacin Succinate	11	suppressed
Telmisartan	Telmisartan	11	suppressed
Terazosin Hcl	Terazosin Hcl	11	suppressed
Tresiba Flextouch U-100	Insulin Degludec	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error